High Absorption Liposomal Nicotinamide Riboside NR Powder CAS 1341-23-7 Bulk Supply Factory Direct
Liposomal
Nicotinamide Riboside
Liposomal Nicotinamide Riboside (NR) Powder delivers 50% or 70% active NR (CAS 1341-23-7) encapsulated within phospholipid bilayer vesicles. NR is a pyridine-nucleoside Vitamin B3 derivative serving as a dietary NAD+ precursor. Liposomal encapsulation addresses NR's hygroscopicity and aqueous degradation challenges — offering manufacturers improved processing stability and batch consistency. GMP-compliant manufacturing with 6+ years of liposomal production experience.
TECHNICAL SPECIFICATIONS
LIPOSOMAL DELIVERY PRINCIPLE
Nicotinamide Riboside (NR) is a pyridine-nucleoside Vitamin B3 derivative and dietary NAD+ precursor. In conventional powder form, NR presents two manufacturing challenges:
(1) pronounced hygroscopicity — absorbing atmospheric moisture during storage and blending, causing active-content degradation and caking;
(2) rapid dissolution in aqueous processing environments, introducing blend-inhomogeneity risks in wet-granulation and beverage powder operations.
Our liposomal encapsulation process disperses NR within phospholipid bilayer vesicles via controlled high-shear emulsification, followed by spray-drying into a free-flowing dry powder. This achieves three outcomes:
(1) a phospholipid moisture barrier that reduces hygroscopic degradation during manufacturing;
(2) controlled aqueous release supporting uniform blend distribution in wet-processing operations;
(3) QC-verified batch consistency — HPLC assay, DLS particle sizing, and EE% ≥ 80% confirmed on every production lot.
KEY ADVANTAGES
1. Dual Loading Flexibility: 50% & 70%
Two standardized grades. 50% offers balanced, cost-efficient dosing for multi-component B3-complex and NAD+ precursor blends. 70% maximizes NR payload per gram — enabling smaller capsules, fewer units per serving, and targeted high-potency single-active NR products. Both grades share identical manufacturing, QC, and CoA documentation protocols.
2. Hygroscopicity-Control Manufacturing
Unencapsulated NR powder is notably hygroscopic — absorbing moisture that accelerates degradation and causes caking. The phospholipid bilayer provides a physical moisture barrier, reducing humidity-driven active-content loss during blending, capsule filling, and warehouse storage. Data demonstrates more stable active retention across extended production runs.
3. Industrial-Scale Batch Consistency
HPLC assay confirms 50% or 70% NR loading per batch. EE% ≥ 80% verifies genuine encapsulation — not simple phospholipid blending. DLS particle sizing confirms uniform 80–300 nm vesicle dimensions batch to batch. Full heavy metal and microbial screening per shipment.
4. Multi-Format Production Compatibility
Free-flowing powder integrates into capsule filling, tablet compression, dry premixes, and stick-pack lines. Compatible with B vitamins, minerals, amino acids, and botanical actives. 25 kg drums, 1 kg foil bags, and custom packaging for OEM contract manufacturing.
QUALITY VERIFICATION
1. HPLC Active Assay
Every batch tested to confirm 50% or 70% NR loading. Batch-specific CoA provided with each shipment.
2. DLS Particle Size Analysis
Confirms stable liposome formation (80–300 nm) upon rehydration, verifying uniform nano-scale vesicle dimensions across production lots.
3. Encapsulation Efficiency (EE%)
EE% ≥ 80% by dialysis/HPLC confirms genuine liposomal encapsulation rather than simple physical blending with phospholipids.
4. Heavy Metal & Microbial Screening
Full compliance: Pb ≤ 10 ppm, As/Cd ≤ 1 ppm, Hg ≤ 0.1 ppm; TPC / Yeast & Mold per USP; E. coli and Salmonella negative per 25g.
FUNCTIONAL ROLES
These statements describe established nutritional roles of Nicotinamide Riboside using structure/function language. They have not been evaluated by regulatory authorities. This product is not intended to diagnose, treat, cure, or prevent any disease.
1. NAD+ Precursor — Cellular Energy Metabolism
NR is a dietary precursor of NAD+, a coenzyme fundamental to mitochondrial oxidative phosphorylation. Formulated into cellular-metabolism and energy-support supplement lines for active-lifestyle and metabolic-health consumer segments.
2. B3-Complex Ingredient
As a pyridine-nucleoside member of the Vitamin B3 family — alongside nicotinic acid and nicotinamide — NR is a differentiated, premium-positioned ingredient for B3-complex and NAD+ precursor supplement formulations.
3. Redox Homeostasis
NAD+ cycles between oxidized and reduced states as a central electron carrier in cellular redox reactions. NR, as an NAD+ precursor, supports the body's endogenous NAD+ metabolism.
4. Multi-Vitamin & Wellness Formulations
A recognizable, premium-positioned B3-family ingredient across multivitamin, B-complex, wellness, and general-nutrition supplement categories. Consistent B2B demand supports stable-volume contract manufacturing.
INDUSTRIAL APPLICATIONS
1. B-Complex & Multivitamin Capsules
50% grade for multi-component B-complex and NAD+ precursor blends. 200–450 mg fill weights; compatible with high-speed capsule filling lines.
2. High-Potency Single-Active NR
70% grade enables 100–300 mg active NR per capsule in compact formats — optimizing capsule size and packaging-to-active ratios for single-active NR SKUs.
3. Functional Beverage Premixes
Both grades compatible with stick packs, sachets, and powdered beverage mixes. Liposomal carrier supports uniform dispersion in multi-phase powder systems.
4. OEM Private Label Formulations
Ready-to-encapsulate NR for private-label NAD+ precursor, B3-complex, and cellular-metabolism supplement lines. Batch-specific CoA and GMP documentation included.
OEM & PACKING
OEM & CUSTOM FORMULATION
CERTIFICATIONS
TRANSPORTATION
PACKAGING
TECHNICAL FAQ
Production line capacity supports multi-ton monthly output. For current slot availability, lead times, and volume-based tier pricing, contact our sales team with your projected annual quantity requirements.
Custom NR loading percentages are available for qualified large-volume OEM projects. Minimum order quantities, development lead times, and feasibility assessment apply. Contact our technical team to discuss your target specification.
Every batch: (1) HPLC assay confirms ordered loading percentage (50% or 70%); (2) DLS particle sizing verifies 80–300 nm liposome dimensions; (3) EE% measurement confirms genuine encapsulation. Batch-specific CoA, heavy metal panel, and microbial screening results included.